Kinsa, the company behind first-ever FDA-cleared smartphone-connected thermometer, has raised $9.6 million in Series A funding from Kleiner Perkins Caufield & Byers (KPCB), FirstMark Capital, Andy Palmer, and others. The investment will be used to help Kinsa quickly scale production, recruit top tier talent, expand marketing activities and the product line. As part of the deal, KPCB partner Beth Seidenberg will be joining Kinsa’s board.

The Kinsa Smart Thermometer connects to a mobile device via the headphone jack to determine a precise temperature reading in less than 10 seconds. Through the accompanying Kinsa mobile app, users can create individual profiles for each member of a family, record and monitor fever and symptoms, easily report the progression of illnesses to physicians, keep track of medication dosages and timing, and document any physical symptoms with photos.

In addition, Kinsa makes temperature-taking fun for kids and easy for parents through interactive screens. Soon, users will also be able to join groups so they may better understand what is “going around” their own circles, such as schools, offices, or neighborhoods.

The Kinsa Smart Thermometer connects to a mobile device via the headphone jack to determine a precise temperature reading in less than 10 seconds.“We’ve reimagined the world’s most common medical device, the thermometer, and given it the potential to improve the health of entire communities,” said Kinsa Founder and CEO Inder Singh.

The Kinsa Smart Thermometer is available at Apple and CVS stores across the United States as well as online at Amazon, Apple.com and Kinsa’s website for $29.99. The Kinsa app is free and available for both iOS and Android-based devices.